Aytu BioScience Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
1.00
314.10
2,562.40
3,221.60
3,660.10
Cost of Goods Sold (COGS) incl. D&A
-
105.70
1,621.80
3,126.10
3,604.20
Gross Income
-
208.40
940.70
95.50
55.90
SG&A Expense
53.70
9,367.20
15,145.10
18,955.60
17,119.10
EBIT
57.50
9,158.80
14,204.40
18,860.10
17,063.20
Unusual Expense
-
-
8,484.20
1,113.80
1,346.90
Non Operating Income/Expense
-
-
-
-
6,277.90
Interest Expense
4.20
138.00
5,491.50
2,534.40
749.40
Pretax Income
61.70
9,296.80
28,180.10
22,508.30
10,187.90
Consolidated Net Income
61.70
9,268.10
28,180.10
22,508.30
10,187.90
Net Income
61.70
9,268.10
28,180.10
22,508.30
10,187.90
Net Income After Extraordinaries
61.70
9,268.10
28,180.10
22,508.30
10,187.90
Net Income Available to Common
61.70
9,268.10
28,180.10
22,508.30
10,187.90
EPS (Basic)
584.45
4,032.06
6,471.85
965.97
15.31
Basic Shares Outstanding
0.10
1.90
4.40
23.30
665.60
EPS (Diluted)
684.11
4,026.20
6,473.79
965.97
15.31
Diluted Shares Outstanding
0.10
1.90
4.40
23.30
665.60
EBITDA
52.70
8,918.60
13,329.60
17,017.30
15,215.50
About Aytu BioScience
View Profile
